Table 2.

Location of brain lesions in MOG antibody vs AQP4 antibody NMOSD.

Location involved	MOG antibody disease, n=14 (%)	AQP4 NMOSD, n=16 (%)	P value
Deep WM	9 (64%)	8 (50%)	0.4837
Pons	8 (57%)	8 (50%)	0.73
Cortical GM/juxtracortical WM	8 (57%)	0 (0%)	0.0005*
Cerebellum	6 (43%)	4 (25%)	0.4421
Corpus callosum	6 (43%)	4 (25%)	0.4421
Midbrain	6 (43%)	3 (18.8)	0.236
Medulla	6 (43%)	7 (43.8%)	1
Periventricular WM	5 (35.7%)	3 (18.8%)	0.4171
Basal ganglia	2 (14.2%)	4 (25%)	0.6567
Area postrema	1 (7%)	8 (50%)	0.0169

^*statistically significant corrected for multiple comparisons (<0.0017).